Adaptimmune is rolling out its T cell therapy Tecelra for synovial sarcoma, recording $1.2 million in sales since its ...

A phase 1 trial has reported positive safety findings of SON-1010 among patients with advanced leiomyosarcoma (LMS) or ...

Despite scoring a historic FDA approval last year, Adaptimmune Therapeutics is expressing concerns about its own longevity, ...

Support poured in for a suburban police officer, who is a father of five boys, as he battled cancer and had to have his foot amputated.

Chemotherapy plus local therapy improved overall survival and disease-free survival when compared to local therapy alone.

rhabdomyo Sarcoma, synovial Sarcoma, leiomyo Sarcoma, and fibro Sarcoma). As sarcoma may arise virtually anywhere, but the extremity is the most common primary site. Despite progress in ...

Multiple presentations demonstrate that T-knife’s proprietary next-generation technologies address important challenges with ...

SO INITIALLY, AFTER MY COUSIN PASSED AWAY FROM SYNOVIAL SARCOMA, I FELT A STRONG NEED TO RAISE AWARENESS AMONG, YOU KNOW, YOUNG ADULTS ABOUT DIFFERENT CANCER TYPES AND THINGS LIKE THAT.

But I'm going to go into more details on this call so that you can see why we're so excited that our long range forecast of at least $400 million in combined synovial sarcoma sales seems very ...